Retraction Watch

How fishy email addresses tipped off a sleuth to a paper mill

Anna Abalkina noticed something odd about a psychology paper on the “modern problems of youth extremism”: The corresponding author was affiliated with a university in Russia, but his email address had a domain name from India.

The unusual domain name was part of a pattern Abalkina, of the Freie Universität Berlin, noticed in hundreds of papers that seemed to have been produced by paper mills.

Six of those papers, including the one on youth extremism, had been published in the Journal of Community Psychology, a Wiley title. Dorothy Bishop, a psychologist at the University of Oxford, conducted a detailed review of the six articles, along with the published referee reports and editorial correspondence on Publons, to see if anything else about them was amiss.

Weekend reads: Autism researcher up to 24 retractions; former prof sues Penn State; vice chancellor under criminal probe for plagiarism

Would you consider a donation to support Weekend Reads, and our daily work?

The week at Retraction Watch featured:

Our list of retracted or withdrawn COVID-19 papers is up to 289. There are more than 38,000 retractions in our database — which powers retraction alerts in EndNote, LibKey, Papers, and Zotero. And have you seen our leaderboard of authors with the most retractions lately — or our list of top 10 most highly cited retracted papers?

Here’s what was happening elsewhere (some of these items may be paywalled, metered access, or require free registration to read):

Prominent Korean heart doctor earns two retractions in a month

Two Korean journals last month pulled papers by a prominent cardiologist at Yonsei University, Professor Hui-Nam Pak, with one retraction notice citing “issues related to scientific misconduct.”

Commenters on PubPeer had raised several concerns about data integrity, “mixed-up” data and “statistical nonsense” in “eNOS3 Genetic Polymorphism Is Related to Post-Ablation Early Recurrence of Atrial Fibrillation,” which was published in 2015 in Yonsei Medical Journal. The journal retracted the paper on January 19, noting that “we have recently become aware of a number of issues related to scientific misconduct.”

The article was coauthored by Patrick Ellinor, acting chief of cardiology at Massachusetts General Hospital, and has been cited six times, according to Clarivate’s Web of Science.

Did David Hume retract 2 essays on immorality to avoid religious controversy?

We may never identify the earliest retracted paper. For the time being, this 1756 article about Benjamin Franklin is the earliest one in our database. And here might be a runner-up, of a sort, from a friend of Franklin’s the following year.

David Hume is widely regarded as one of the most influential philosophers of his or any age. His writings on causality, reason, and empiricism, as well as his history of England, were considered masterpieces when they appeared in the 18th century.

In 1757, Hume published a collection of previously released works under the title “Four Dissertations,” which helped – if that’s the right word – cement his reputation as one of the age’s leading skeptics about religion.

Former Harvard researchers lose PNAS paper for reusing data

A group of cancer researchers once all based at Harvard have earned a retraction after acknowledging data duplication “errors” in an article published more than eight years ago.

The paper, “Synthetic lethality of combined glutaminase and Hsp90 inhibition in mTORC1-driven tumor cells,” was published in the Proceedings of the National Academy of Sciences (PNAS) in December 2014. It has been cited 52 times, according to Clarivate’s Web of Science. The study informed a clinical trial from Infinity Pharmaceuticals on a drug for people with lung cancer, according to Dimensions, a scientific research database.

Starting in November 2020, the paper drew scrutiny from commenters on PubPeer. The posts include claims of duplications in several of the paper’s figures; none of the authors has responded to the 10 comments on the site.

Scholar calls journal decision on ‘comfort women’ paper ‘rotten at the core’

The journal that published a hotly contested article by a professor at Harvard Law School arguing that Korean women forced into sexual slavery during World War II were willing prostitutes has reaffirmed a prior expression of concern over the paper, but stopped short of retracting the article.

However, the International Review of Law and Economics encourages readers of the article, by Mark Ramseyer, to “also consult the comments published in IRLE and in other venues for the broader historical perspective.”

Alexis Dudden, a professor of history at the University of Connecticut who has written extensively about Japan’s wartime system of military sexual slavery, called the statement “wishy-washy.”

“For the denialists, this is a victory,” she told Retraction Watch. “The IRLE decision is rotten at the core.”

Exclusive: Deepfake pioneer to lose two papers after misconduct finding of faked data

Two papers coauthored by a computer scientist whose work on visual effects has been credited in big-name Hollywood movies will soon be retracted after a publisher’s investigation found falsification of data in the articles.

Retraction Watch has also learned that the University of Southern California (USC) found that Hao Li “falsely presented his research” in the two publications while he was a professor there. The articles, both published in journals of the Association for Computing Machinery (ACM), describe a system to create a 3D digital avatar head from a person’s photo using artificial intelligence.

Li co-founded and is CEO of Pinscreen, a startup which is commercializing that technology. On its website, Pinscreen touts its products as “the most advanced AI-driven versatile avatars.” Besides personalized avatars for use in virtual or augmented reality systems, Pinscreen offers the ability to replace a person’s face in videos, creating what’s known as “deepfakes.”

Weekend reads: ‘Against Reviewer 2;’ forced to grant guest authorships; problems in oversight of bat virus research in China

Would you consider a donation to support Weekend Reads, and our daily work?

The week at Retraction Watch featured:

Here’s what was happening elsewhere (some of these items may be paywalled, metered access, or require free registration to read):

‘Kafkaesque nightmare’: Judge wants researcher reinstated as NIH grant PI after med school’s misconduct finding

A federal judge has denied a request for a preliminary injunction by a breast cancer researcher at SUNY Downstate in Brooklyn who sued the university last year after an institutional investigation determined that she committed research misconduct.

However, the judge noted “troubling aspects of this case that bear on serious public health concerns” – namely the discontinuation of the scientist’s research – and also expressed concern about SUNY Downstate and the NIH’s treatment of her.

As we’ve previously reported, Stacy Blain, an associate professor of pediatrics and cell biology at SUNY Downstate, has alleged the university discriminated against her for decades because of her sex, and that the investigation’s finding of misconduct was the result of retaliation after she complained of the discrimination.

Publisher investigating “serious concerns” about article on ivermectin, COVID, and the microbiome

The publisher Frontiers has published an expression of concern for an article that proposed “ivermectin protects against COVID-19” via effects on the microbiome.

The article, “Microbiome-Based Hypothesis on Ivermectin’s Mechanism in COVID-19: Ivermectin Feeds Bifidobacteria to Boost Immunity,” was published in July 2022 in Frontiers in Microbiology. The sole author, Sabine Hazan, is affiliated with ProgenaBiome, a company based in Ventura, Calif. that “spearheads the movement of validating, verifying, and clinically applying its sequencing data, to better understand the microbiome.”

The abstract of the article stated:

Share this:

Share this:

Share this:

Share this:

Share this:

Share this:

Share this:

Share this:

Share this:

Share this: